Personalized Medicine To Be HHS Focus In Administration’s Final Thousand Days, Leavitt Says
HHS Secretary says “reinventing” FDA’s regulatory process and providing new financing mechanisms will be essential to bring about personalized therapies.
HHS Secretary says “reinventing” FDA’s regulatory process and providing new financing mechanisms will be essential to bring about personalized therapies.